Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients (Q44561660)

4 December 2017

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients (English)

1 reference

4 December 2017

12

1 reference

4 December 2017

Alisan Kahraman

1

1 reference

4 December 2017

Jan-Peter Sowa

2

1 reference

4 December 2017

Martin Schlattjan

3

1 reference

4 December 2017

Svenja Sydor

4

1 reference

4 December 2017

Martin Pronadl

5

1 reference

4 December 2017

Alexander Wree

6

1 reference

4 December 2017

Anja Beilfuss

7

1 reference

4 December 2017

Alpaslan Kilicarslan

8

1 reference

4 December 2017

Akif Altinbaş

9

1 reference

4 December 2017

Lars Peter Bechmann

10

1 reference

4 December 2017

Wing-Kin Syn

11

1 reference

4 December 2017

Ali Canbay

13

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

4 December 2017

1 reference

4 December 2017

125

1 reference

4 December 2017

8

1 reference

4 December 2017

391-400

1 reference

Current therapeutic strategies in non-alcoholic fatty liver disease.

4 December 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Comparison of electrophysiologic monitors with clinical assessment of level of sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

New clinical score to diagnose nonalcoholic steatohepatitis in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Obesity affects the liver - the link between adipocytes and hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Preoperative predictors of weight loss following bariatric surgery: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Short versus long Roux-limb length in Roux-en-Y gastric bypass surgery for the treatment of morbid and super obesity: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

A review of laparoscopic sleeve gastrectomy for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Genes and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Mechanisms of disease progression in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Metabolic surgery-principles and current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

The epidemiology of nonalcoholic fatty liver disease: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

The role of adipose tissue and adipokines in obesity-related inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Adiponectin and its receptors in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Adipocytokines and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Lipid mobilization following Roux-en-Y gastric bypass examined by magnetic resonance imaging and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120542

21 January 2018

Identifiers

DOI

10.1042/CS20120542

1 reference

4 December 2017

1 reference